Concord Investment Counsel »

iShares NASDAQ Biotechnology Index shares owned by Concord Investment Counsel

Quarter-by-quarter ownership of iShares NASDAQ Biotechnology Index (IBB) shares owned by Concord Investment Counsel from 13F filings

Historical chart of Concord Investment Counsel investment in iShares NASDAQ Biotechnology Index

Tip: Access up to 7 years of quarterly data

All positions including iShares NASDAQ Biotechnology Index held by Concord Investment Counsel consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares NASDAQ Biotechnology Index by Concord Investment Counsel

Quarter filed Position value Share count Share price at filing
2024-03-31 $4.5M 33k 137.22

More positions owned by Concord Investment Counsel

NVIDIA Corporation (NVDA)
Apple (AAPL)
Select Sector Spdr Tr Indl (XLI)
Amazon (AMZN)
Microsoft Corporation (MSFT)
UnitedHealth (UNH)
Alphabet Cap Stk Cl A (GOOGL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Meta Platforms Cl A (META)
Select Sector Spdr Tr Sbi Cons Stpls (XLP)
Select Sector Spdr Tr Energy (XLE)
Netflix (NFLX)
JPMorgan Chase & Co. (JPM)
Select Sector Spdr Tr Technology (XLK)
Bank of America Corporation (BAC)

View all positions for Concord Investment Counsel

Top funds holding iShares NASDAQ Biotechnology Index

Bank of America Corporation
Bnp Paribas Arbitrage, Snc
Susquehanna International
Citigroup
Farallon Capital Management
Jane Street
PEAK6 Investments
Royal Bank of Canada
Goldman Sachs Group
Citadel Advisors
UBS Group
Wells Fargo & Company
Commerce Bank N A
Healthcare Of Ontario Pension Plan Trust Fund
LPL Financial

View all funds holding iShares NASDAQ Biotechnology Index